The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) by Garnier Jean Pierre since 2006.
The trader's CIK number is 1184175.
At the time of the last reporting, Garnier Jean Pierre was the Director of Radius Health, Inc.. (stock ticker symbol RDUS).
Also see all insider trading activities at Radius Health, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2019 | RDUS | 0 | $0 | 0 | $0 | 4,800 | $0 |
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2015 | UTX | 0 | $0 | 6,000 | $717,738 | 6,000 | $303,150 |
| 2013 | UTX | 0 | $0 | 15,000 | $1,496,026 | 15,000 | $552,795 |
| 2011 | UTX | 0 | $0 | 3,555 | $258,665 | 5,000 | $187,500 |
| 2007 | UTX | 0 | $0 | 4,725 | $353,406 | 8,000 | $196,872 |
| 2006 | UTX | 0 | $0 | 2,175 | $126,171 | 8,000 | $149,000 |
2. Raytheon Technologies Corp (UTX)
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2019-02-13 | RDUS | Option Ex | 4,800 | .00 | 0 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2015-03-16 | UTX | Option Ex | 6,000 | 50.52 | 303,150 |
| 2015-03-16 | UTX | Sale | 6,000 | 119.62 | 717,738 |
| 2013-11-25 | UTX | Option Ex | 7,000 | 44.09 | 308,595 |
| 2013-11-25 | UTX | Sale | 7,000 | 110.50 | 773,514 |
| 2013-02-27 | UTX | Option Ex | 8,000 | 30.52 | 244,200 |
| 2013-02-27 | UTX | Sale | 8,000 | 90.31 | 722,512 |
| 2011-12-19 | UTX | Option Ex | 5,000 | 37.50 | 187,500 |
| 2011-12-19 | UTX | Sale | 3,555 | 72.76 | 258,665 |
| 2007-11-13 | UTX | Option Ex | 8,000 | 24.61 | 196,872 |
| 2007-11-13 | UTX | Sale | 4,725 | 74.80 | 353,406 |
| 2006-03-13 | UTX | Option Ex | 8,000 | 18.62 | 149,000 |
| 2006-03-14 | UTX | Sale | 2,175 | 58.01 | 126,171 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Garnier Jean Pierre (Director of Radius Health, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.